DarioHealth Corp. financial data

Symbol
DRIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
322 W 57 Th St. #33 B, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
LabStyle Innovations Corp. (to 7/27/2016)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 350 % -23.4%
Quick Ratio 36.9 % -26.8%
Return On Equity -74.6 % -3.35%
Return On Assets -44 % +10.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30M shares +10.3%
Common Stock, Shares, Outstanding 30M shares +12.1%
Entity Public Float 98.2M USD -25.4%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 39.8M shares +41.3%
Weighted Average Number of Shares Outstanding, Diluted 39.8M shares +41.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 23.3M USD +16.7%
General and Administrative Expense 21.4M USD +37.9%
Operating Income (Loss) -63.8M USD -27.6%
Nonoperating Income (Expense) 11.1M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -52.7M USD +17.9%
Income Tax Expense (Benefit) -1.99M USD
Net Income (Loss) Attributable to Parent -50.8M USD +11.9%
Earnings Per Share, Basic 1.18 USD/shares -43.5%
Earnings Per Share, Diluted 1.18 USD/shares -43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.9M USD -56.4%
Inventory, Net 5.13M USD -13.2%
Other Assets, Current 250K USD +4.6%
Assets, Current 39.3M USD -40.2%
Property, Plant and Equipment, Net 1.33M USD +63.3%
Operating Lease, Right-of-Use Asset 1.55M USD +44.4%
Intangible Assets, Net (Excluding Goodwill) 22.3M USD +191%
Goodwill 57.4M USD +37.9%
Assets 122M USD +4.25%
Employee-related Liabilities, Current 4.07M USD -7.58%
Accrued Liabilities, Current 2.23M USD +1.92%
Contract with Customer, Liability, Current 1.52M USD +92%
Liabilities, Current 17.4M USD +116%
Deferred Income Tax Liabilities, Net 2.43M USD -2.21%
Operating Lease, Liability, Noncurrent 1.12M USD +26.3%
Other Liabilities, Noncurrent 51K USD +41.7%
Retained Earnings (Accumulated Deficit) -363M USD -14.7%
Stockholders' Equity Attributable to Parent 68.1M USD -13.2%
Liabilities and Equity 122M USD +4.25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD -176%
Net Cash Provided by (Used in) Financing Activities 20.2M USD
Net Cash Provided by (Used in) Investing Activities -8.85M USD -103%
Common Stock, Shares Authorized 160M shares 0%
Common Stock, Shares, Issued 30M shares +12.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.6M USD -55.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 986K USD -8.02%
Deferred Tax Assets, Valuation Allowance 58.3M USD +11%
Deferred Tax Assets, Gross 60.7M USD +10.4%
Operating Lease, Liability 996K USD -11.1%
Depreciation 110K USD +13.4%
Payments to Acquire Property, Plant, and Equipment 56K USD -24.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.5M USD +22.6%
Lessee, Operating Lease, Liability, to be Paid 1.27M USD -2.31%
Property, Plant and Equipment, Gross 2.39M USD +7.23%
Operating Lease, Liability, Current 884K USD +510%
Lessee, Operating Lease, Liability, to be Paid, Year Two 305K USD +6.27%
Lessee, Operating Lease, Liability, to be Paid, Year One 124K USD -59.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +47.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 275K USD +51.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 279K USD +11.6%
Preferred Stock, Shares Issued 40.3K shares +113%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 279K USD +21.3%
Additional Paid in Capital 432M USD +9.15%
Preferred Stock, Shares Outstanding 40.3K shares +113%
Amortization of Intangible Assets 1.22M USD +9.25%
Deferred Tax Assets, Net of Valuation Allowance 2.43M USD -2.21%
Share-based Payment Arrangement, Expense 6.86M USD +41.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%